IBDEI1VT ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33104,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,33105,0)
 ;;=M26.60^^182^1998^153
 ;;^UTILITY(U,$J,358.3,33105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33105,1,3,0)
 ;;=3^Temporomandibular Joint Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,33105,1,4,0)
 ;;=4^M26.60
 ;;^UTILITY(U,$J,358.3,33105,2)
 ;;=^5011714
 ;;^UTILITY(U,$J,358.3,33106,0)
 ;;=L40.52^^182^1998^110
 ;;^UTILITY(U,$J,358.3,33106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33106,1,3,0)
 ;;=3^Psoriatic Arthritis Mutilans
 ;;^UTILITY(U,$J,358.3,33106,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,33106,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,33107,0)
 ;;=L40.53^^182^1998^111
 ;;^UTILITY(U,$J,358.3,33107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33107,1,3,0)
 ;;=3^Psoriatic Spondylitis
 ;;^UTILITY(U,$J,358.3,33107,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,33107,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,33108,0)
 ;;=M32.9^^182^1998^152
 ;;^UTILITY(U,$J,358.3,33108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33108,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,33108,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,33108,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,33109,0)
 ;;=M32.0^^182^1998^148
 ;;^UTILITY(U,$J,358.3,33109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33109,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
 ;;^UTILITY(U,$J,358.3,33109,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,33109,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,33110,0)
 ;;=M32.13^^182^1998^150
 ;;^UTILITY(U,$J,358.3,33110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33110,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
 ;;^UTILITY(U,$J,358.3,33110,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,33110,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,33111,0)
 ;;=M32.14^^182^1998^149
 ;;^UTILITY(U,$J,358.3,33111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33111,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Glomerular Disease
 ;;^UTILITY(U,$J,358.3,33111,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,33111,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,33112,0)
 ;;=M32.12^^182^1998^151
 ;;^UTILITY(U,$J,358.3,33112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33112,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Pericarditis
 ;;^UTILITY(U,$J,358.3,33112,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,33112,2)
 ;;=^5011755
 ;;^UTILITY(U,$J,358.3,33113,0)
 ;;=M05.59^^182^1998^132
 ;;^UTILITY(U,$J,358.3,33113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33113,1,3,0)
 ;;=3^Rheumatoid Polyneuropathy w/ Rheumatoid Arthritis of Mult Sites
 ;;^UTILITY(U,$J,358.3,33113,1,4,0)
 ;;=4^M05.59
 ;;^UTILITY(U,$J,358.3,33113,2)
 ;;=^5009976
 ;;^UTILITY(U,$J,358.3,33114,0)
 ;;=M05.711^^182^1998^126
 ;;^UTILITY(U,$J,358.3,33114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33114,1,3,0)
 ;;=3^Rheumatoid Arthritis of Right Shoulder
 ;;^UTILITY(U,$J,358.3,33114,1,4,0)
 ;;=4^M05.711
 ;;^UTILITY(U,$J,358.3,33114,2)
 ;;=^5010001
 ;;^UTILITY(U,$J,358.3,33115,0)
 ;;=M05.712^^182^1998^119
 ;;^UTILITY(U,$J,358.3,33115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33115,1,3,0)
 ;;=3^Rheumatoid Arthritis of Left Shoulder
 ;;^UTILITY(U,$J,358.3,33115,1,4,0)
 ;;=4^M05.712
 ;;^UTILITY(U,$J,358.3,33115,2)
 ;;=^5010002
 ;;^UTILITY(U,$J,358.3,33116,0)
 ;;=M05.731^^182^1998^127
 ;;^UTILITY(U,$J,358.3,33116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33116,1,3,0)
 ;;=3^Rheumatoid Arthritis of Right Wrist
 ;;^UTILITY(U,$J,358.3,33116,1,4,0)
 ;;=4^M05.731
 ;;^UTILITY(U,$J,358.3,33116,2)
 ;;=^5010007
 ;;^UTILITY(U,$J,358.3,33117,0)
 ;;=M05.732^^182^1998^120
 ;;^UTILITY(U,$J,358.3,33117,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1VT
